M Coppola, R Mondola
文献索引:Toxicol. Lett. 218(1) , 24-9, (2013)
全文:HTML全文
In 2010, an internet snapshot of EMCDDA anticipated the presence of 5-iodo-2-aminoindan (5-IAI) within the recreational drug market. In 2011, this compound, a psychoactive derivative of 2-aminoindane, was identified in recreational products sold in the United Kingdom. 5-IAI is a rigid analogue of p-iodoamphetamine producing MDMA-like effects. The aim of this paper is to summarize the clinical, pharmacological, and toxicological information about this new potential drug of abuse.Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.